Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Sep. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment									2
Segment Reporting Information [Line Items]
Number of reportable segments | segment									2
Net sales	$ 5,202,000	$ 4,479,000	$ 4,493,000	$ 4,275,000	$ 4,701,000	$ 4,160,000	$ 4,294,000	$ 3,953,000	$ 18,449,000	$ 17,108,000	$ 14,351,000
Depreciation and amortization									1,278,000	1,272,000	1,076,000
Segment net earnings (loss)									2,841,000	2,584,000	2,223,000
Amortization of intangible assets									(627,000)	(619,000)	(472,000)
Goodwill impairment									(216,000)	0	0
Net earnings (loss)	$ 563,000	$ 816,000	$ 656,000	$ 323,000	$ 662,000	$ 438,000	$ 592,000	$ 302,000	2,358,000	1,994,000	1,599,000
MedSurg and Neurotechnology
Segment Reporting Information [Line Items]
Net sales									10,611,000	9,538,000	8,345,000
Goodwill impairment									0
Orthopaedics and Spine
Segment Reporting Information [Line Items]
Net sales									7,838,000	7,570,000	6,006,000
Goodwill impairment									(216,000)
Operating Segments
Segment Reporting Information [Line Items]
Depreciation and amortization									1,154,000	1,147,000	954,000
Segment operating income									5,033,000	4,987,000	4,002,000
Operating Segments | MedSurg and Neurotechnology
Segment Reporting Information [Line Items]
Net sales									10,611,000	9,538,000	8,345,000
Depreciation and amortization									540,000	518,000	496,000
Segment net earnings (loss)									2,737,000	2,807,000	2,414,000
Operating Segments | Orthopaedics and Spine
Segment Reporting Information [Line Items]
Net sales									7,838,000	7,570,000	6,006,000
Depreciation and amortization									614,000	629,000	458,000
Segment net earnings (loss)									2,296,000	2,180,000	1,588,000
Corporate
Segment Reporting Information [Line Items]
Depreciation and amortization									124,000	125,000	122,000
Segment Reconciling Items
Segment Reporting Information [Line Items]
Segment operating income									(649,000)	(605,000)	(503,000)
Acquisition and integration-related charges									(150,000)	(585,000)	(242,000)
Amortization of intangible assets									(627,000)	(619,000)	(472,000)
Restructuring-related and other charges									(349,000)	(386,000)	(458,000)
Goodwill impairment									(216,000)	0	0
Medical device regulations									(140,000)	(107,000)	(81,000)
Recall-related matters									15,000	(103,000)	(17,000)
Regulatory and legal matters									(76,000)	2,000	(6,000)
Net earnings (loss)									$ 2,841,000	$ 2,584,000	$ 2,223,000